FDA recall D-0446-2017

Sun Pharmaceutical Industries, Inc. · Class III · drug

Product

buPROPion Hydrochloride Extended-release Tablets, USP (SR), 200 mg, 60 count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India NDC 47335-0738-86

Reason for recall

Failed Dissolution Specifications; 18 month stability time point

Distribution

Nationwide

Key facts

Status
Terminated
Initiation date
2016-12-20
Report date
2017-02-01
Termination date
2018-07-11
Voluntary/Mandated
Voluntary: Firm initiated
Location
Cranbury, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0446-2017